ARCHIVED - Summative Evaluation of the Blood Safety Contribution Program - Final Report
II. Blood Safety Contribution Program
Brief description of BSCP
An effective surveillance system for recipients of blood and blood products provides information to assess the magnitude of new or emerging risks, monitor the trends of known risks, and evaluate the effectiveness of actions taken to reduce the risks.
The objectives of the BSCP are to:Footnote 1
- Develop linkages with public health information systems in order to strengthen public health responses to blood-borne pathogen (BBP) threats.
- Develop linkages with appropriate organizations so that the statistical integration of CIDPC databases with other external databases can be implemented.
- Acquire the professional and staffing resources for statistical analysis, policy development and appropriate follow-up action to develop analytic and response capacities within.
- Establish co-coordinated research thrusts into new potential blood-borne threats, including prion diseases, which include the human form of “mad-cow disease” known as Creutzfeldt-Jakob Disease (CJD).
The ultimate outcome of the BSCP program is to develop mitigation strategies for risks associated with the use of blood, blood products or transplantation of cells, tissues and organs (BSCP iRMAF/RBAF, 2008, pp. 8-9).
Overall, there are five complementary components, which together form the necessary elements of a fully comprehensive transfusion/transplantation injuries surveillance system. The National Working Party for Data Review (NWPDR) supports all program elements. The five components that form the BSCP are all grants and contributions initiatives, as follows:
- Provincial/territorial adverse events surveillance initiatives [Transfusion Transmitted Injuries Surveillance System (TTISS)];
- Error surveillance related to blood transfusions [Transfusion Errors Surveillance System (TESS)];
- Cells, tissues, and organ transplant surveillance [Cells, Tissues and Organs Surveillance System (CTOSS)];
- Data linkages and communications; and
- High risk populations and emerging pathogens.
The BSCP iRMAF/RBAF (2008) states that the recipients of BSCP funds are both implementation partners and beneficiaries. The main purpose of distributing funding is to build capacity for surveillance. Most, but not all, of the projects funded involve a data export component. Some projects focus on high-risk populations. Eligible recipients are provincial and territorial governments and not-for-profit Canadian organizations, designated transfusion and/or transplantation centres, and agencies and/or groups designated by provincial and territorial Ministries of Health to undertake surveillance for blood/tissue/organ associated adverse events.
- Date modified: